Gothenburg, Sweden

Kaj Blennow

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kaj Blennow. Retrieved from https://idiyas.com/inventor/kaj-blennow-qog6vfou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaj Blennow: Innovator in Alzheimer's Disease Research

Introduction

Kaj Blennow is a prominent inventor based in Gothenburg, Sweden. He has made significant contributions to the field of Alzheimer's disease research. His innovative work focuses on the diagnosis and treatment of this debilitating condition.

Latest Patents

Kaj Blennow holds a patent related to the diagnosis and treatment of Alzheimer's disease. The patent outlines methods for the prevention, treatment, and diagnosis of Alzheimer's disease, based on the glycosylation pattern of amyloid-beta peptides found in body fluids and tissues. This groundbreaking approach has the potential to enhance the understanding and management of Alzheimer's disease.

Career Highlights

Throughout his career, Kaj Blennow has established himself as a leading figure in Alzheimer's research. His work has garnered attention for its innovative methodologies and practical applications in the medical field. He continues to be an influential voice in the ongoing fight against Alzheimer's disease.

Collaborations

Kaj Blennow has collaborated with notable professionals in his field, including Jonas A Nilsson and Adnan Fevzi Halim. These partnerships have furthered the impact of his research and contributed to advancements in Alzheimer's disease treatment and diagnosis.

Conclusion

Kaj Blennow's contributions to Alzheimer's disease research are invaluable. His innovative patent and collaborative efforts highlight his commitment to improving the lives of those affected by this condition. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…